Cargando…
Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
In this study, we used patient-specific and isogenic PARK2-induced pluripotent stem cells (iPSCs) to show that mutations in PARK2 alter neuronal proliferation. The percentage of TH(+) neurons was decreased in Parkinson’s disease (PD) patient-derived neurons carrying various mutations in PARK2 compar...
Autores principales: | Shaltouki, Atossa, Sivapatham, Renuka, Pei, Ying, Gerencser, Akos A., Momčilović, Olga, Rao, Mahendra S., Zeng, Xianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437475/ https://www.ncbi.nlm.nih.gov/pubmed/25843045 http://dx.doi.org/10.1016/j.stemcr.2015.02.019 |
Ejemplares similares
-
Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
por: Momcilovic, Olga, et al.
Publicado: (2016) -
A platform for rapid generation of single and multiplexed reporters in human iPSC lines
por: Pei, Ying, et al.
Publicado: (2015) -
Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
por: Okarmus, Justyna, et al.
Publicado: (2021) -
Characterization of Dopaminergic System in the Striatum of Young Adult Park2(−/−) Knockout Rats
por: Gemechu, Jickssa M., et al.
Publicado: (2018) -
Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
por: Mazza, Melissa Conti, et al.
Publicado: (2021)